Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1997;76(9):1234–1240. doi: 10.1038/bjc.1997.540

Invasive lobular carcinoma of the breast has better short- and long-term survival than invasive ductal carcinoma.

S Toikkanen 1, L Pylkkänen 1, H Joensuu 1
PMCID: PMC2228126  PMID: 9365176

Abstract

The outcome and prognostic factors of 217 women with invasive lobular carcinoma (ILC) and those of 1121 women with invasive ductal carcinoma (IDC) of the breast were compared. The patients were followed up for 10-43 years. Women with ILC had axillary nodal metastases less frequently than those with IDC (43% vs 53%, P = 0.02), although there was no difference in the primary tumour size between the groups. ILCs were more frequently of low grade, had lower mitotic counts and had less tumour necrosis. Furthermore, ILCs had lower S-phase fractions and were more often DNA diploid in flow cytometric analysis than IDCs (P < 0.0001 for all comparisons). The 5- and 30-year corrected survival rates of women with ILC were 78% and 50%, respectively, compared with 63% and 37% for women with IDC (P = 0.001). Small pT1NOMO ILCs (n = 41) had 100% 10-year and 83% 20-year corrected survival rates. In a multivariate analysis, a large primary tumour size, the presence of axillary nodal metastases, a high mitotic count and the presence of tumour necrosis all had an independent prognostic value in ILC. We conclude that ILC is associated with better survival than IDC.

Full text

PDF
1234

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. DiCostanzo D., Rosen P. P., Gareen I., Franklin S., Lesser M. Prognosis in infiltrating lobular carcinoma. An analysis of "classical" and variant tumors. Am J Surg Pathol. 1990 Jan;14(1):12–23. doi: 10.1097/00000478-199001000-00002. [DOI] [PubMed] [Google Scholar]
  2. Dixon J. M., Anderson T. J., Page D. L., Lee D., Duffy S. W. Infiltrating lobular carcinoma of the breast. Histopathology. 1982 Mar;6(2):149–161. doi: 10.1111/j.1365-2559.1982.tb02712.x. [DOI] [PubMed] [Google Scholar]
  3. Eusebi V., Betts C., Haagensen D. E., Jr, Gugliotta P., Bussolati G., Azzopardi J. G. Apocrine differentiation in lobular carcinoma of the breast: a morphologic, immunologic, and ultrastructural study. Hum Pathol. 1984 Feb;15(2):134–140. doi: 10.1016/s0046-8177(84)80053-2. [DOI] [PubMed] [Google Scholar]
  4. Fechner R. E. Histologic variants of infiltrating lobular carcinoma of the breast. Hum Pathol. 1975 May;6(3):373–378. doi: 10.1016/s0046-8177(75)80099-2. [DOI] [PubMed] [Google Scholar]
  5. Fechner R. E. Infiltrating lobular carcinoma without lobular carcinoma in situ. Cancer. 1972 Jun;29(6):1539–1545. doi: 10.1002/1097-0142(197206)29:6<1539::aid-cncr2820290618>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  6. Fisher E. R., Gregorio R. M., Fisher B., Redmond C., Vellios F., Sommers S. C. The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4). Cancer. 1975 Jul;36(1):1–85. doi: 10.1002/1097-0142(197507)36:1<1::aid-cncr2820360102>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  7. Fisher E. R., Gregorio R. M., Redmond C., Fisher B. Tubulolobular invasive breast cancer: a variant of lobular invasive cancer. Hum Pathol. 1977 Nov;8(6):679–683. doi: 10.1016/s0046-8177(77)80096-8. [DOI] [PubMed] [Google Scholar]
  8. Gardner G. A., Stewart D. J. Changes in the free amino and other nitrogen compounds in stored beef muscle. J Sci Food Agric. 1966 Nov;17(10):491–496. doi: 10.1002/jsfa.2740171103. [DOI] [PubMed] [Google Scholar]
  9. Helin H. J., Helle M. J., Kallioniemi O. P., Isola J. J. Immunohistochemical determination of estrogen and progesterone receptors in human breast carcinoma. Correlation with histopathology and DNA flow cytometry. Cancer. 1989 May 1;63(9):1761–1767. doi: 10.1002/1097-0142(19900501)63:9<1761::aid-cncr2820630918>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  10. Howell A., Harris M. Infiltrating lobular carcinoma of the breast. Br Med J (Clin Res Ed) 1985 Nov 16;291(6506):1371–1372. doi: 10.1136/bmj.291.6506.1371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Joensuu H., Pylkkänen L., Toikkanen S. Bcl-2 protein expression and long-term survival in breast cancer. Am J Pathol. 1994 Nov;145(5):1191–1198. [PMC free article] [PubMed] [Google Scholar]
  12. Joensuu H., Toikkanen S. Cured of breast cancer? J Clin Oncol. 1995 Jan;13(1):62–69. doi: 10.1200/JCO.1995.13.1.62. [DOI] [PubMed] [Google Scholar]
  13. Martinez V., Azzopardi J. G. Invasive lobular carcinoma of the breast: incidence and variants. Histopathology. 1979 Nov;3(6):467–488. doi: 10.1111/j.1365-2559.1979.tb03029.x. [DOI] [PubMed] [Google Scholar]
  14. Newman W. Lobular carcinoma of the female breast. Report of 73 cases. Ann Surg. 1966 Aug;164(2):305–314. doi: 10.1097/00000658-196608000-00018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Rosen P. P., Lesser M. L., Arroyo C. D., Cranor M., Borgen P., Norton L. p53 in node-negative breast carcinoma: an immunohistochemical study of epidemiologic risk factors, histologic features, and prognosis. J Clin Oncol. 1995 Apr;13(4):821–830. doi: 10.1200/JCO.1995.13.4.821. [DOI] [PubMed] [Google Scholar]
  16. Sastre-Garau X., Jouve M., Asselain B., Vincent-Salomon A., Beuzeboc P., Dorval T., Durand J. C., Fourquet A., Pouillart P. Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer. 1996 Jan 1;77(1):113–120. doi: 10.1002/(SICI)1097-0142(19960101)77:1<113::AID-CNCR19>3.0.CO;2-8. [DOI] [PubMed] [Google Scholar]
  17. Silverstein M. J., Lewinsky B. S., Waisman J. R., Gierson E. D., Colburn W. J., Senofsky G. M., Gamagami P. Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma? Cancer. 1994 Mar 15;73(6):1673–1677. doi: 10.1002/1097-0142(19940315)73:6<1673::aid-cncr2820730620>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  18. Steinbrecher J. S., Silverberg S. G. Signet-ring cell carcinoma of the breast. The mucinous variant of infiltrating lobular carcinoma? Cancer. 1976 Feb;37(2):828–840. doi: 10.1002/1097-0142(197602)37:2<828::aid-cncr2820370231>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  19. Toikkanen S., Helin H., Isola J., Joensuu H. Prognostic significance of HER-2 oncoprotein expression in breast cancer: a 30-year follow-up. J Clin Oncol. 1992 Jul;10(7):1044–1048. doi: 10.1200/JCO.1992.10.7.1044. [DOI] [PubMed] [Google Scholar]
  20. Toikkanen S., Joensuu H., Klemi P. The prognostic significance of nuclear DNA content in invasive breast cancer--a study with long-term follow-up. Br J Cancer. 1989 Nov;60(5):693–700. doi: 10.1038/bjc.1989.342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. du Toit R. S., Locker A. P., Ellis I. O., Elston C. W., Nicholson R. I., Robertson J. F., Blamey R. W. An evaluation of differences in prognosis, recurrence patterns and receptor status between invasive lobular and other invasive carcinomas of the breast. Eur J Surg Oncol. 1991 Jun;17(3):251–257. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES